Rhythm Pharmaceuticals (RYTM) had the highest return between August 1, 2022 and September 30, 2022 by a mid-cap US stock, returning 96.8%.
| ASSET | DATE | % RETURN |
|---|---|---|
Rhythm Pharmaceuticals (RYTM) | 8/1/2022 - 9/30/2022 | 96.79% |
Verona Pharma PLC ADR (VRNA) | 8/1/2022 - 9/30/2022 | 80.25% |
Xometry (XMTR) | 8/1/2022 - 9/30/2022 | 51.32% |
Bausch Health Companies (BHC) | 8/1/2022 - 9/30/2022 | 49.13% |
Wave Life Sciences (WVE) | 8/1/2022 - 9/30/2022 | 43.25% |
Weatherford International (WFRD) | 8/1/2022 - 9/30/2022 | 42.88% |
Penumbra (PEN) | 8/1/2022 - 9/30/2022 | 38.27% |
Enovix (ENVX) | 8/1/2022 - 9/30/2022 | 37.86% |
Immunovant (IMVT) | 8/1/2022 - 9/30/2022 | 37.78% |
Palomar (PLMR) | 8/1/2022 - 9/30/2022 | 36% |
Nuvalent (NUVL) | 8/1/2022 - 9/30/2022 | 33.42% |
Clearwater Analytics (CWAN) | 8/1/2022 - 9/30/2022 | 32.2% |
PureCycle Technologies (PCTTW) | 8/1/2022 - 9/30/2022 | 30.77% |
Immunitybio (IBRX) | 8/1/2022 - 9/30/2022 | 30.45% |
Blueprint Medicines (BPMC) | 8/1/2022 - 9/30/2022 | 30.27% |
Melco Resorts & Entertainment (MLCO) | 8/1/2022 - 9/30/2022 | 29.24% |
Zeta Global (ZETA) | 8/1/2022 - 9/30/2022 | 29.1% |
Recursion Pharmaceuticals (RXRX) | 8/1/2022 - 9/30/2022 | 28.81% |
Torm PLC Class A (TRMD) | 8/1/2022 - 9/30/2022 | 25.91% |
Catalyst Pharmaceuticals (CPRX) | 8/1/2022 - 9/30/2022 | 25.78% |
MoonLake Immunotherapeutics (MLTX) | 8/1/2022 - 9/30/2022 | 25.57% |
Corporacion America Airports (CAAP) | 8/1/2022 - 9/30/2022 | 25.05% |
Vera Therapeutics (VERA) | 8/1/2022 - 9/30/2022 | 24.99% |
Intapp (INTA) | 8/1/2022 - 9/30/2022 | 24.72% |
Geron (GERN) | 8/1/2022 - 9/30/2022 | 24.47% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
